scholarly journals OP31.02: Changes in endometriomas and rectovaginal endometriotic nodules during treatment with norethindrone acetate or extended-cycle oral contraceptive

2017 ◽  
Vol 50 ◽  
pp. 149-150
Author(s):  
C. Scala ◽  
C. Bondi ◽  
F. Laraud ◽  
P.L. Venturini ◽  
V. Vellone ◽  
...  
2001 ◽  
Vol 1 (3) ◽  
pp. 123-131 ◽  
Author(s):  
J. Michael Maloney ◽  
Deborah I. Arbit ◽  
Mary Flack ◽  
Constance McLaughlin-Miley ◽  
Cynthia Sevilla ◽  
...  

2010 ◽  
Vol 2 ◽  
pp. CMT.S4661
Author(s):  
Radhika Rible ◽  
Ram Parvataneni ◽  
Angela Chen

Extended-cycle combined hormonal contraception has become a common practice among women seeking effective contraception and menstrual regulation. Extended cycle regimens have the benefit of decreasing scheduled bleeding as compared to traditional combined oral contraceptive (COC) regimens containing 21 days of hormones followed by a 7-day hormone-free interval (HFI) by reducing the frequency of the HFI. The newest FDA approved product in this family of contraceptive regimens is a 91-day COC regimen containing 0.02 mg ethinyl estradiol (EE) and 0.1 mg levonorgestrel (LNG) for 84 days followed by a 7-day interval with 0.01 mg EE. This regimen has been evaluated in one pivotal trial and demonstrated to have efficacy and a side effect profile similar to the other currently available FDA approved 91-day extended-cycle regimens. This is the first 91-day regimen formulated with 0.02 mg EE and offers women an effective option for contraception and menstrual cycle control.


1970 ◽  
Vol 53 (4) ◽  
pp. 831-833
Author(s):  
John Y P Wu

Abstract Norethindrone, norethindrone acetate, dimethisterone, medroxyprogesterone acetate, and norethynodrel are determined in oral contraceptive tablets. For the first 4 compounds, a chloroform extract of the tablets is treated directly with isonicotinyl hydrazide reagent to produce a stable color which is measured at 380 nm. The chloroform extract of norethynodrel tablets is isomerized before the reagent is added. An intralaboratory study gave good results, with standard deviations of 0.74 to 1.21%. A collaborative study is recommended.


Contraception ◽  
2011 ◽  
Vol 84 (2) ◽  
pp. 133-143 ◽  
Author(s):  
Inka Wiegratz ◽  
Skadi Stahlberg ◽  
Torsten Manthey ◽  
Nicole Sänger ◽  
Katrin Mittmann ◽  
...  

2007 ◽  
Vol 3 (5) ◽  
pp. 529-535 ◽  
Author(s):  
Anita L Nelson

The elimination of monthly withdrawal bleeding with use of extended-cycle (84 pills) monophasic birth-control pills has modernized oral contraceptives. The use of ethinyl estradiol 10 μg pills in place of the seven placebo pills addresses the problems posed by 21/7 formulations of low-dose birth-control pills, which allow early stimulation of ovarian follicles, and of the early 84/7 formulations, which had higher rates of unscheduled bleeding and spotting.


Contraception ◽  
2005 ◽  
Vol 71 (1) ◽  
pp. 55-59 ◽  
Author(s):  
Freedolph D. Anderson ◽  
Howard Hait ◽  
Jeng Hsiu ◽  
Allison L. Thompson-Graves ◽  
Walter H. Wilborn ◽  
...  

1983 ◽  
Vol 62 (1) ◽  
pp. 71-76 ◽  
Author(s):  
N. N. Sarkar ◽  
V. Laumas ◽  
N. Agarwal ◽  
V. Hingorani ◽  
K. R. Laumas

Sign in / Sign up

Export Citation Format

Share Document